All reports

KCE Reports 381C (2024) Forecasts of future spending on medicines are currently based mainly on past spending and trends. However, this approach does not adequately predict the impact of very expensive emerging drugs, such as cell and gene therapies. To identify those products and prepare the system for their arrival, the pharmaceutical pipeline needs to be systematically monitored. This is known as horizon scanning. KCE has issued recommendations to better predict future spending on pharmaceuticals, with particular emphasis on horizon scanning.

KCE Reports 341C (2021) Add-on to “Performance of the Belgian health system – report 2019” This report is an add-on to a previous KCE report published in 2019 that assessed the performance of the Belgian health system (KCE Report 313). 

KCE Reports 334C (2020) Unfortunately not everyone is in good health and some people need to have recourse to healthcare more than others. In our Belgian system, which is based on solidarity, efforts are made to reduce these inequalities as far as is possible.

KCE Reports 309C (2019) The Belgian compulsory health insurance is not only an insurance scheme that reimburses health costs; it is also a solidarity system designed to reduce inequalities. It does this through two mechanisms: by income redistribution (high-income groups contribute more than low-income groups) and by cross-subsidies from low to high health risks.